Correlation Between Marvell Technology and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Marvell Technology and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marvell Technology and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marvell Technology Group and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Marvell Technology and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marvell Technology with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marvell Technology and Telix Pharmaceuticals.
Diversification Opportunities for Marvell Technology and Telix Pharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Marvell and Telix is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Marvell Technology Group and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Marvell Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marvell Technology Group are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Marvell Technology i.e., Marvell Technology and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between Marvell Technology and Telix Pharmaceuticals
Given the investment horizon of 90 days Marvell Technology Group is expected to generate 0.78 times more return on investment than Telix Pharmaceuticals. However, Marvell Technology Group is 1.27 times less risky than Telix Pharmaceuticals. It trades about 0.22 of its potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.07 per unit of risk. If you would invest 8,344 in Marvell Technology Group on August 29, 2024 and sell it today you would earn a total of 970.00 from holding Marvell Technology Group or generate 11.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Marvell Technology Group vs. Telix Pharmaceuticals Limited
Performance |
| Timeline |
| Marvell Technology |
| Telix Pharmaceuticals |
Marvell Technology and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Marvell Technology and Telix Pharmaceuticals
The main advantage of trading using opposite Marvell Technology and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marvell Technology position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.The idea behind Marvell Technology Group and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |